Author

Ross O. Youngs

ORCID 0009-0009-7422-8378Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Research Focus:database / resource· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Assay:metagenomics· 1

Frequent Co-Authors

Lindsey Ahn· 1 shared Matthew J. BertiniD· 1 shared Michaela Burkhauser· 1 shared Runjie Xia· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Lindsey Ahn

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BiochemistrybioRxivPreprintFeb 9, 2026

Expanding CyanoHAB Monitoring: New Micropeptins and Generalizable MS/MS Workflows for the Annotation of Cyanopeptide Classes

Runjie Xia, Lindsey Ahn, Michaela Burkhauser…·Matthew J. Bertin

The paper identifies new micropeptins and develops an LC-MS/MS workflow for annotating cyanopeptide classes, challenging microcystin-centric monitoring of harmful algal blooms.

DOI 10.64898/2026.02.07.704577

metagenomicsdeep learning

𝕏 PostBluesky

Pharmacology & ToxicologybioRxivPreprintOct 29, 2025

Reversing Erooms Law- Finitude and Dilution in Small-Molecule Discovery

Ross Youngs

The paper identifies two factors causing declining drug discovery productivity and proposes a hybrid strategy combining natural products and synthetic chemistry to reverse Erooms Law.

DOI 10.1101/2025.10.29.685434

drug response / drug discoverybenchmarking

𝕏 PostBluesky